Vyzulta | Beye

Compare IOP Reduction

15 products »

Home > Ophthalmic Drugs > IOP Reduction

Vyzulta

Vyzulta

Bausch + Lomb Inc.

Vyzulta (latanoprostene bound ophthalmic solution 0.024%), is a prostaglandin analog indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. Vyzulta is the first prostaglandin analog with one of its metabolites being nitric oxide (NO).

TOP

Description

Related Products

Details

From Your Peers

Company

At-a-Glance

Mechanism of Action: Latanoprostene bunod is thought to lower intraocular pressure by increasing outflow of aqueous humor through both the trabecular meshwork and uveoscleral routes. Intraocular pressure is a major modifiable risk factor for glaucoma progression. Reduction of intraocular pressure reduces risk of glaucomatous visual field loss.
Dosage: One drop in the affected eye(s) once daily in the evening.

Details

FDA

Yes

CE Mark

Yes

Active Ingredients

Latanoprostene bunod

Application

Topical

Status

Prescription

Strength

0.024%

From Your Peers

Options Expanding for IOP Lowering

Options Expanding for IOP Lowering

READ ARTICLE »

Show More

Company Information

Contact the company for additional information, availability, or pricing:

Bausch + Lomb Inc.

bausch.com

400 Somerset Corporate Blvd.

Bridgewater, NJ 08807

Compare IOP Reduction »

15 products »

View All IOP Reduction »

15 products »

Privacy | Terms & Conditions Ⓒ 2024 Beye, LLC. All rights reserved.

This content is intended for health care professionals and providers only. The information contained on Beye.com, including text, graphics, images, and interactive activities, is for informational purposes only, and is not intended to be a substitute for professional medical advice. Beye LLC, via its Editors and Publisher, accepts no responsibility for any injury or damage to persons or property occasioned through the implementation of any ideas or use of any product described herein. Although great care is taken to ensure that all information is accurate, it is recommended that readers seek independent verification of advice on drugs and other product usage, surgical techniques and clinical processes prior to their use. References made in article may indicate usage of medical equipment or drugs at dosages, for periods of time, and in combination not included in the current prescribing information. Inclusion of advertising materials on the website thereof, does not constitute and representation or guarantee by Beye LLC of the quality of such products, or of the claims made.